1st Circ. To Review Crucial Issue In Teva, Regeneron Cases
The First Circuit on Friday granted Teva Pharmaceutical's request to settle how rigorous the causation standard should be in federal False Claims Act kickback cases, a legal issue that has previously...To view the full article, register now.
Already a subscriber? Click here to view full article